Company Research Report: Rx Bandz

Company Overview

• Name: Rx Bandz, Inc.

• Mission: Developed the next generation of patient-centric auto-injectors to deliver a wide range of injectable medications by anyone, anytime, anywhere.

• Founded by: No information is available.

• Key People:

• Jessica Walsh - Founder, CEO

• Harsha Murthy - Chief Strategy Officer

• Myrna Walsh - Chief Administrative Officer

• Dr. Michael Blaiss MD, FACAAI - Chief Medical Officer

• Dr. Sean Hollonbeck MD, MP, COL (ret) - VP of Medical Affairs

• Stephen Harhen - Chief Technology Officer

• Thomas Gardner - VP of Regulatory Affairs

• Headquarters:

• 100 Feeks Lane, Ste C1, Locust Valley, NY 11560

• Innovation Center: 4 Edison Place, Ste A, Fairfield, NJ 07004

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: Rx Bandz is known for its innovative, patient-centric auto-injectors, particularly the MiniJect, which is the world's smallest auto-injector, and solutions for various medical fields like anaphylaxis, diabetes, vaccines, opioid overdose, and more.

Products

MiniJect - 1mL

• Description: World's smallest rugged and durable auto-injector, designed for immediate safe medication delivery.

• Key Features:

• Two-step operation

• Compact and lightweight (1.2 ounces)

• Versatile drug delivery

• Fast injection time (0.4 seconds)

• Fully retractable needle

• Designed to 810H Mil standards (waterproof, IR/UV resistant)

OmniJect - 3mL

• Description: Advanced auto-injector capable of accommodating larger fill volumes.

• Key Features:

• Customizable injection time

• Visual and audible feedback

• Configurable for IM or SubQ injections

MultiJect - Double Dose

• Description: Designed for dual-chamber dosing.

• Key Features:

• Two-cartridge dosing

• Customizable injection time

• Visual and audible feedback

• Configurable for IM or SubQ injections

General Product Features

• Waterproof and sterile

• Temperature resilient

• One-sided operation

• High reliability and rugged durability

• Designed for patient, military, and emergency settings

Recent Developments

• New Partnerships:

• Partnered with Weiss-Aug for precision manufacturing.

• Supported by NEPDC and SW Pediatric Consortium for pediatric healthcare innovations.

• New Products/Features:

• The company has been awarded several DoD SBIR/STTR Phase I & II R&D Contracts to adapt auto-injectors for military use.

• Innovations to extend the shelf life of Epinephrine are on track.

• Rx Bandz recognizes new investments from Leonid Capital Partners.

• Projects in Development:

• Military Development Pipeline includes:

• Glass Cartridge Protection

• Epinephrine and Hydromorphone to Phase II

• Atropine for anti-chemical warfare in Phase I

• TXA for hemorrhages in Phase II

• Recognition:

• Received the International Innovation Life Science Award.

• Received $23M in contracts from the Air Force Advanced Medical Readiness Agency.

• Recognized by Jt. Base San Antonio-Lackland.